Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-IMG-131821

Xenbase Image ID: 131821


Fig. 1. (A) Deletion analysis of ICD. Diagram of the X-Notch-1 intracellular domain (ICD) and of the deletions used for mapping ESR-1 induction. NLS-Ank contains the SV40 NLS at the Nterminus (Rupp et al., 1994). The amino acid residues (Coffman et al., 1990) encompassed by each truncation are indicated. The right column summarizes the data from RNase protection assays, such as those shown in Fig. 3, that measure the ability of each construct to induce ESR-1 expression in neuralized animal caps (+++, 100%; ++, 20-40%; +, 10-20%; +/-, 1-5%; or -, not detectable). RAM23 (Tamura et al., 1995) is the subtransmembrane region. Addition of the SV40 NLS (Rupp et al., 1994) to the N terminus of ICD22, 23, 24, and 25 did not alter ESR-1 induction. (B) Different forms of XSu( H)1. Schematic representation of wild-type X-Su(H)1, a form in which the ankyrin repeats from Notch are fused to the carboxy terminus (X-Su(H)1/Ank), a form in which four residues required for DNA binding, between amino acids 193-203, are altered (XSu( H)1DBM), a truncated form in which the carboxy terminal 117 amino acids are deleted X-Su(H)1-Tr, and a form of X-Su(H)1/Ank fused to the hormone binding domain of the human glucocorticoid receptor (hGR).

Image published in: Wettstein DA et al. (1997)

Copyright © 1997. Image reproduced with permission of the publisher and the copyright holder. This is an Open Access article distributed under the terms of the Creative Commons Attribution License.

Larger Image
Printer Friendly View

Return to previous page